McNeil recalls Infant's Tylenol over package design flaw

FORT WASHINGTON, Pa. — McNeil Consumer Healthcare on Friday issued a voluntary recall, at the wholesale and retail levels, of seven lots of Infants' Tylenol oral suspension 1-oz. grape that was distributed nationwide over consumer complaints of the included dosing system.

McNeil's Infants' Tylenol SimpleMeasure includes a dosing syringe, which a parent or caregiver inserts into a protective cover, or “flow restrictor,” at the top of the bottle to measure the proper dose. In some cases, the flow restrictor was pushed into the bottle when inserting the syringe.

No adverse events associated with this action have been reported to date, and the risk of a serious adverse medical event is remote.

Consumers can continue to use Infants' Tylenol, provided the flow restrictor at the top of the bottle remains in place. If the flow restrictor is pushed into the bottle, the parent or caregiver should not use the product.

Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.